New insights into the HPV virus
A scientific study from HEAP researchers at Karolinska Institutet and the University of Oulu reveals that gender-neutral HPV vaccination is the best way to achieve community-level immune protection and to eradicate vaccine-targeted oncogenic HPVs. The study, published in the journal Cell Host & Microbe, analysed cohort data from the community-randomised Finnish vaccination trial, and found that […]
Save the date. The First International Consumer Purchase Data Symposium. 27th September 2023
HEAP Consortia partner Statens Serum Institut (SSI) is hosting a Consumer Purchase Data and Health (CPD) Symposium on Wednesday, 27th September 2023, from 12:30-17:00 CEST, to be held in Copenhagen and online. With topics ranging from practical uses of CPD via outbreak investigations to chemical exposures, and nutrition, the symposium will touch upon the vast […]
How personal exposome monitors could change healthcare
A HEAP abstract presented at the EHEN Scientific Meeting 2023 in Leuven, Belgium. By capturing and analysing the bacteria, virus and fungi that surround us on a daily basis, wearable sensors could provide personalised predictions of how likely we are to develop certain diseases, or to provide insights to ways we could safeguard our health. […]
HEAP symposium – Epigenetics and personalised preventative medicine
Can we predict someone’s risk of developing cancer by looking at their DNA markers? In her contribution to the HEAP symposium highlights series, Chiara Herzog, Postdoctoral researcher. European Translational Oncology Prevention and Screening (EUTOPS) Institute, University of Innsbruck, presents the HEAP Lifestyle cohort, and her research into risk identification (WID) for breast or ovarian cancers […]
HEAP symposium – Personal exposome profiling
Can we prove that someone has been exposed to certain chemicals that have affected their health? In his contribution to the HEAP symposium highlights series, Michael Snyder, Director of the Center for Genomics and Personalized Medicine at Stanford University, presents his research into individualized environmental exposures. The research compared thousands of chemical and biological components […]
HEAP symposium – the promise of informatics and precision medicine
The next frontier of exposome research will focus on genomics, transcriptomics, proteomics, and metabolomics, and seek to identify optimal treatments for individual patients. In the next instalment of the HEAP Symposium highlights series, HEAP project coordinator Professor Joakim Dillner explores the potential of informatics to make Precision Medicine a reality. He then outlines the six […]
HEAP symposium – “Biobanking and the exposome”
As part of HEAP\’s \”Symposium Highlights\” series, Kurt Zatloukal, Head of the Diagnostic and Research Center for Molecular BioMedicine, Medical University Graz, and Director of BBMRI.at, Austria, discusses how biobanks could add value to exposome research in a 15-minute presentation. Biobanks have expertise in collecting, preserving and providing access to biosamples, as well as processing […]
TEDx talk – the case for a data driven approach to health policy
The notion of sharing data during public health emergencies is generally accepted, and has been a cornerstone of the COVID-19 pandemic response. But should data sharing be limited to emergencies or a few high-priority threats? We now have the technology to enable near real-time, broad-based, continuous information, and a collaborative framework for data collection, sharing, analysis, […]